AbbVie a new outperform at RBC Capital Markets on durable growth
Source: SeekingAlpha
2026-02-25 11:59:52 ET
More on AbbVie
- AbbVie: Dominating Immunology While Building Oncology Upside
- AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
- AbbVie: The Market Is Getting It Wrong
- AbbVie earmarks $380M to build two manufacturing facilities in Illinois
- AbbVie wins FDA nod for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia
Read the full article on Seeking Alpha
For further details see:
AbbVie a new outperform at RBC Capital Markets on durable growth
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
-0.97% G/L:
$224.48 Last:
1,406,476 Volume:
$226.89 Open:
ABBV Latest News
March 13, 2026 01:36:56 pm
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
